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httpsWHAT THIS PAPER ADDS
This paper provides a novel and unique comparison of amputation practices among patients with peripheral
arterial disease (PAD) in 12 European and Australasian countries participating in the VASCUNET collaboration.
The authors discovered important differences, which may indicate disparities in access to vascular surgical
intervention across the countries studied. This paper further aims to harmonise medical treatment to achieve
the best possible overall outcomes for PAD patients.Objectives: To study international differences in incidence and practice patterns as well as time trends in lower
limb amputations related to peripheral arterial disease and/or diabetes mellitus.
Methods: Data on lower limb amputations during 2010e2014 were collected from population based
administrative data from countries in Europe and Australasia participating in the VASCUNET collaboration.
Amputation rates, time trends, in hospital or 30 day mortality and reimbursement systems were analysed.
Results: Data from 12 countries covering 259 million inhabitants in 2014 were included. Individuals aged  65
years ranged from 12.9% (Slovakia) to 20.7% (Germany) and diabetes prevalence among amputees from 25.7%
(Finland) to 74.3% (Slovakia). The mean incidence of major amputation varied between 7.2/100,000 (New
Zealand) and 41.4/100,000 (Hungary), with an overall declining time trend with the exception of Slovakia, while
minor amputations increased over time. The older age group (65 years) was up to 4.9 times more likely to be
amputated compared with those younger than 65 years. Reported mortality rates were lowest in Finland (6.3%)
and highest in Hungary (20.3%). Countries with a fee for service reimbursement system had a lower incidence of
major amputation compared with countries with a population based reimbursement system (14.3/100,000
versus 18.4/100,000, respectively, p < .001).
Conclusions: This international audit showed large geographical differences in major amputation rates, by a
factor of almost six, and an overall declining time trend during the 4 year observation of this study. Diabetes
prevalence, age distribution, and mortality rates were also found to vary between countries. Despite limitations
attributable to registry data, these ﬁndings are important, and warrant further research on how to improve limb
salvage in different demographic settings.
 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
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Peripheral arterial disease (PAD) and diabetes are the major
causes of lower limb amputation throughout the world.1 A
recent systematic review reported that more than 202
million inhabitants are affected by PAD worldwide with a
substantial increase in prevalence over time, emphasizing
Table 1. Ofﬁcial demographics (data source: EUROSTAT), amputation rates, proportion of diabetics among amputees, and in hospital
mortality as reported by the representatives of this study.
Country Total no.
of
inhabitants
in 2014
Population
65 years
or older
in 2014 (%)
Major
amputations
per 100,000
2010e2014
Minor
amputations
per 100,000
2010e2014
Diabetics
among
amputees
mean (%)
Major
amputees:
In hospital
mortality
mean (%)
Re-
imbursement
system
Germany 80,767,463 16,799,632
(20.80)
2010: 20.0 2010: 35.9 66.82 18.54 FFS
2011: 19.0 2011: 36.7
2012: 18.5 2012: 37.5
2013: 18.4 2013: 39.2
2014: 17.6 2014: 39.2
United
Kingdom
54,316,618 9,537,708 (17.56) 2010: 9.5 2010: 13.4 53.74 7.68 PB
2011: 9.1 2011: 13.8
2012: 8.6 2012: 13.9
2013: 8.7 2013: 15.2
2014: 8.2 2014: 15.1
Spain 46,452,771 8,511,020 (18.32) 2010: 7.6 2010: 7.4 65.64 NDA FFS
2011: 7.7 2011: 7.6
2012: 7.6 2012: 8.1
2013: 7.7 2013: 8.7
2014: 7.6 2014: 8.4
Australia 23,460,694 3,456,188 (14.73) 2010: 9.1 2010: 26.7 73.50 NDA FFS
2011: 8.7 2011: 28.2
2012: 8.0 2012: 29.0
2013: 8.4 2013: 29.0
2014: 7.5 2014: 30.0
Hungary 9,877,365 1,748,021 (17.70) 2010: 42.3 2010: 34.1 55.16 20.88 PB
2011: 41.5 2011: 33.7
2012: 41.4 2012: 33.7
2013: 42.3 2013: 33.0
2014: 39.6 2014: 33.6
Sweden 9,747,355 1,912,884 (19.62) 2010: 12.7 2010: 2.9 41.28 14.52 PB
2011: 11.9 2011: 2.8
2012: 12.9 2012: 3.0
2013: 11.7 2013: 2.8
2014: NDA 2014: NDA
Austria 8,543,932 1,571,996 (18.40) 2010: 23.6 2010: 22.7 NDA 14.29 FFS
2011: 23.1 2011: 24.0
2012: 23.4 2012: 23.0
2013: 22.1 2013: 15.4
2014: 21.0 2014: 15.5
Denmark 5,639,719 1,040,682 (18.45) 2010: 18.5 2010: 8.9 43.44 NDA PB
2011: 17.3 2011: 9.0
2012: 19.0 2012: 8.5
2013: 18.7 2013: 9.8
2014: 17.5 2014: 10.1
Finland 5,471,753 1,091,388 (19.95) 2010: 18.9 2010: 17.0 25.73 6.12 PB
2011: 18.1 2011: 19.2
2012: 17.4 2012: 19.6
2013: 17.8 2013: 20.7
2014: 17.7 2014: 20.3
Slovakia 5,415,949 661,800 (13.54) 2010: 27.4 2010: 45.4 74.32 NDA PB
2011: 28.3 2011: 38.9
2012: 30.6 2012: 48.5
2013: 29.0 2013: 48.9
2014: 30.2 2014: 51.6
Norway 5,165,802 834,302 (16.15) 2010: 11.8 2010: 5.2 47.41 6.27 PB
2011: 12.0 2011: 5.6
2012: 11.6 2012: 5.1
2013: 10.2 2013: 4.5
2014: 10.4 2014: 4.6
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Table 1-continued
Country Total no.
of
inhabitants
in 2014
Population
65 years
or older
in 2014 (%)
Major
amputations
per 100,000
2010e2014
Minor
amputations
per 100,000
2010e2014
Diabetics
among
amputees
mean (%)
Major
amputees:
In hospital
mortality
mean (%)
Re-
imbursement
system
New
Zealand
4,554,600 662,400 (14.54) 2010: 7.6 2010: 10.1 54.53 NDA PB
2011: 7.6 2011: 8.7
2012: 7.3 2012: 10.0
2013: 7.4 2013: 10.8
2014: 6.1 2014: 7.0
Table sorted by population number. FFS ¼ fee for service; PB ¼ population based; NDA ¼ no data available.
International Variations in Amputation Practice 393the global burden of this disease.2 In parallel, the latest
International Diabetes Federation (IDF) Diabetes Atlas
revealed a 7.3% (5.5e10.9%) increase in the age adjusted
prevalence of diabetes among persons aged 20e79 years,
causing 627,000 premature deaths in 2015.3,4 Morbidity
and mortality data related to lower limb amputations show
exceptionally poor results, a ﬁnding that may partly be
explained by gaps in basic patient care and treatment
following an amputation.5 Moreover, the economic burden
of caring for amputees within the healthcare system is
substantial.6
The signiﬁcant impact of these procedures on well being
and health expenditure7 underline the importance of assess-
ing the trends and practice patterns in lower limb amputations
related to PAD and diabetes. Several countries have already
reported national major and/or minor amputation rates using
administrative data.8e14 Although most studies revealed
decreasing incidences of major amputations,8,13 the numbers
of minor amputations increased simultaneously.10,12,13 There
are a lack of data covering amputation practice and outcomes
internationally, as well as wide variation in published results.15
Data collection, merging, and analysis of amputation proced-
ures and results following an amputation on a broad interna-
tional level are complicated because of incompleteness ofdata
sets, differences in the administrative healthcare systems, and
a relative lack of standardisation of procedural and diagnosis
codes internationally. Additionally, many different medical
specialties are involved in the treatment of amputees.
Furthermore, every patient can be amputated on two sides
and at different levels, which inﬂuence the data analysis and
comparison of outcomes. In an effort to enforce the discussion
and to emphasise the need for further research regarding
these problems, this study aimed to compare international
practice patterns and time trends in lower limb major ampu-
tation related to PAD or diabetes using population based
administrative data from 12 countries in Europe and
Australasia.METHODS
The VASCUNET collaboration
VASCUNET is a collaboration of vascular registries from
Europe and Australasia, administered and partly funded by
the European Society for Vascular Surgery (ESVS). It was
founded in 1997, and several contributions have beenpublished since.16,17 VASCUNET aims to increase knowledge
and understanding of vascular disease, and to promote
excellence in vascular surgery, by means of international
vascular audit.
A data extraction and study protocol were developed,
based on expert consensus (Table S1). For this study, national
statistics were used to determine in hospital major andminor
amputations using the International Classiﬁcation of Diseases
(ICD-10) coding I70 (Atherosclerosis), I74 (Arterial embolism
or thrombosis), or I73.9 (Embolism and thrombosis of un-
speciﬁed artery), and Procedure Codes (ICD-9-CM) coding for
major (84.10, 84.14, 84.15, 84.17, 84.18, 84.19) or minor
(84.11, 84.12, 84.13) amputations of the lower limb.The four
Scandinavian registries have speciﬁcally designed operative
procedure codes, according to the Nordic Medico-Statistical
Committee (NOMESCO) Classiﬁcation of Surgical Proced-
ures. Austria is using an individually adapted ICD-10 coding
system. The study included procedures conducted between
January 1, 2010 and December 31, 2014. The numbers of
major (above ankle level) and minor amputations (below
ankle level) for vascular disease were requested, the number
of all diabetics among the target population, and the per-
centage of diabetics among amputees. Post-operative mor-
talitywas deﬁned as in hospitalmortality among all countries,
except for Sweden and Denmark in which it was death within
30 days of the amputation that was reported (Table S2).
Population data were accessed through the Statistical Ofﬁce
of the European Union (EUROSTAT). Data on life expectancy,
gross domestic product (GDP) per capita, proportion of active
and never-smokers, and estimated expenditures for health
care were accessed through the Organisation for Economic
Co-operation and Development (OECD). Data were reques-
ted by the VASCUNET representatives (Australia, Denmark,
Finland, Germany, Hungary, New Zealand, Norway, United
Kingdom, and Sweden) or directly from the national author-
ities in Austria, Spain, and Slovakia. Swedish data were
extracted and submitted from an ongoing observational
cohort study collecting data from different ofﬁcial data
sources.18 CAB collected and coordinated the data set.
Countries were also grouped and analysed by whether
they primarily use fee for service (FFS), where physician’s
payment is proportional to the number of procedures
performed, or population based (PB) reimbursement, where
physician’s payment is independent of the number of pro-
cedures performed.
Figure 1. (A) Total population, diabetes prevalence, and population
aged 65 years or older (mean values in grey boxes). Figure sorted
by population number. Source of data: EUROSTAT, National Federal
Statistics, and International Diabetes Federation Atlas (2015). (B)
Life expectancy in years. Source: Organisation for Economic Co-
operation and Development (OECD). (C) Gross domestic product
(GDP) per capita and estimated expenditures for health care in %.
Source: Organisation for Economic Co-operation and Development
(OECD) aggregated national accounts and health expenditure and
ﬁnancing.
Figure 2. Annual number of major amputations per 100,000 in-
habitants. Mean values (2010e2014) for each country in brackets.
The dashed line in grey shows mean annual incidence among all
countries (Europe and Australasia). (At, Austria; Au, Australia; Dk,
Denmark; Fi, Finland; De, Germany; Hu, Hungary; Nz, New Zealand;
No, Norway; Sk, Slovakia; Es, Spain; Sw, Sweden;Uk, United Kingdom).
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The data were primarily analysed using descriptive statis-
tics, mean and standard deviations for continuous variables,
and relative frequencies for categorical variables. Quanti-
tative data were further visually displayed in ﬁgures and
tables. Rates and univariable differences were compared
using Fisher’s exact test.Ethical considerations
Several review boards determined that retrospectively us-
ing aggregated data from national statistics is not human
subject research, as de-identiﬁed data sets were used. Thus,
patient informed consent was not obtained for this study.
Ethical approval was, however, obtained for the Swedish
data set (the Regional Ethical Review Board at the Univer-
sity of Gothenburg, Sweden, approved the study under the
reference number 649e14 and T784e16).
RESULTS
Twelve countries, of which eight had PB reimbursement,
submitted data to this study covering a total of 259 million
inhabitants in 2014 (Table 1). The proportion of elderly
(deﬁned as 65 years) varied between 12.9% in Slovakia and
20.7% in Germany (Fig. 1A). The estimated life expectancy
varied between 75.3 years in Hungary and 82.8 years in Spain
(Fig. 1B). The national gross domestic product (GDP) per
capita varied between 23,500 US Dollars in Hungary and
63,700 US Dollars in Norway, while the estimated
Figure 3. Annual number of minor amputations per 100,000 in-
habitants. Mean values (2010e2014) for each country in brackets.
The dashed line in grey shows mean annual incidence among all
countries (Europe and Australasia). (At, Austria; Au, Australia; Dk,
Denmark; Fi, Finland; De, Germany; Hu, Hungary; Nz, New Zealand;
Sk, Slovakia; Es, Spain). No valid (unknown external validity) data
available for Sweden, Norway, and United Kingdom.
Figure 4. Comparison of diabetics among amputees, major am-
putations per 100,000 inhabitants, and minor amputations per
100,000 inhabitants.
International Variations in Amputation Practice 395expenditures for health care varied between 4.9% in Hungary
and 9.1% in Germany (Fig. 1C). Diabetes prevalence among
amputees was available for 11 countries and varied between
25.7% (Finland) and 74.3% (Slovakia) (Table 1). The mean
incidence of major amputations ranged between 7.2/
100,000 in New Zealand and 41.4/100,000 in Hungary
(Fig. 2). The mean incidence of minor amputations ranged
between 8.0/100,000 in Spain and 46.7/100,000 in Slovakia
(Fig. 3). While annual incidences of major amputations
decreased from 2010 to 2014, except for Slovakia, minor
amputations increased during the same time period (Figs. 2
and 3). In hospital mortality following major and minor am-
putations varied signiﬁcantly between the participating
countries. The lowest in hospital mortality following major
amputation was reported from Finland (6.12%), while the
highest was reported from Hungary (20.88%) (Table 1).
While the proportion of diabetes among amputees was
slightly higher in countries with FFS reimbursement system
(52.7%) compared with countries with a PB reimbursement
system (49.7%), the incidence of major amputations (14.3/
100,000 vs. 18.4/100,000) was lower in countries with FFS
(p < .001). In contrast, the incidence of minor amputations
(23.6/100,000 vs. 17.9/100,000) was higher in countries
with FFS (p < .001) (Fig. 4). The incidence of major ampu-
tations was 3.5 (Hungary) to 4.9 (Sweden) times higher
among the elderly compared with all age groups (Fig. 5).
While the proportion of active smokers among in-
habitants  15 years varied from 11.9% in Sweden to 25.8%in Hungary, the proportion of never smokers varied from
70.0% in Austria to 83.3% in Sweden (Fig. 6).DISCUSSION
In this large international survey on amputation rates for
PAD, signiﬁcant differences were identiﬁed between coun-
tries regarding amputation practices and outcomes. Firstly,
the number of amputations performed per 100,000 popu-
lation varied considerably between countries, being highest
in Hungary and lowest in New Zealand with an overall
declining trend for major amputations, except for Slovakia.
Secondly, risk factors such as diabetes prevalence and age,
differed between participating countries. A high prevalence
of diabetes was reported in the total population of Slovakia,
Spain, Germany, and New Zealand, according to data
extracted from the International Diabetes Federation. The
proportion of elderly was lowest in Slovakia and New Zea-
land. The highest proportion of active smokers was reported
in the population of Hungary, Austria, Spain, and Slovakia.
Thirdly, major amputations were less common in FFS
countries compared with countries with PB reimbursement
systems. In addition, major amputations were more
frequent in countries with lowest GDP per capita and
healthcare expenditures (Hungary, Slovakia).
Variation in amputation rates may be explained by mul-
tiple background factors such as differences in disease
burden and comorbidities, where diabetes in particular has
a great impact.19 Other predictive factors for amputation
are low socio-economic status20 and economic factors. In
addition, differences in vascular maintenance and the
number of vascular surgeons per 100,000 inhabitants may
play a role. This information, however, could not be
collected in this analysis. A higher amputation rate was
found among PB reimbursed countries compared with
those with a FFS system. As these complex associations
cannot be analysed in a simplistic way, the overall GDP per
Figure 5. Ratio of major amputations among old inhabitants (65 years) in relation to major amputations in total population. (Data range
for Denmark: 2011e2014, Data range for Sweden: 2010e2013, No data available: Slovakia, Norway, Australia).
396 Christian-Alexander Behrendt et al.capita and estimated healthcare expenditures may serve as
a suitable composite covariable. Again, highest major
amputation rates were found in countries with lowest GDP
and healthcare expenditures (Hungary, Slovakia). Healthcare
systems vary within countries. In the US it has been shown
that low income and non-insured patients are more likely to
have an amputation compared with afﬂuent patients more
frequently beneﬁtting from lower extremity revascularisa-
tions.21 Rowe et al. document major amputations and
revascularisation procedures at 28% and 54% among pri-
vate insurance patients and 47% and 26% among the
Medicare population, respectively, thus highlighting the
inverse relationship.8 This is in line with previous VASCUNET
reports that revealed differences in operative management
depending on the health economic system: a patient with
an asymptomatic carotid artery stenosis or a small aortic
aneurysm was more likely to be treated in countries with
FFS compared with PB reimbursement systems.22,23 Other
confounding factors may be lifestyle factors such asFigure 6. Proportion of active smokers in % (left) and never smokers
Development (OECD).smoking habits. In a recently published review article,
smoking together with male sex were identiﬁed as two
predisposing risk factors for amputation among diabetic
patients.24 According to the Organisation for Economic Co-
operation and Development (OECD), the proportion of
active smokers was greater in countries with the highest
major amputation rates (Hungary, Slovakia, Austria). Infor-
mation on national preventive medicine (e.g. smoking
cessation programs) was not available, and thus not taken
into account. Moreover, the proportion of never smokers in
the population was highest in countries with lowest major
amputation rates (Sweden, UK, Norway) (Fig. 6).
Furthermore, there are several important differences in
treatment practices. The availability of professional wound
care, best medical treatment, technical equipment, avail-
ability of vascular specialists with expertise to provide
endovascular or open revascularisations, and the general
healthcare infrastructure to transfer patients between fa-
cilities varies signiﬁcantly among participating countries andin % (right). Source: Organisation for Economic Co-operation and
International Variations in Amputation Practice 397is likely to inﬂuence limb salvage rates. A previous VAS-
CUNET report concerning lower limb bypass surgery
conﬁrmed signiﬁcant differences: in Finland, 25 per 100,000
patients were offered bypass surgery, compared with the
UK where 2,3 per 100,000 patients were operated on.16 The
amputation practice variation is partly a reﬂection of the
aggressiveness of limb salvage, as well the countries’
amputation prevention programs, mainly diabetic foot
management. Unfortunately, data on primary amputation
versus amputation after limb salvage attempt are not
available in this data set. In earlier published data from
Hungary, primary amputations without a revascularisation
procedure were performed in 71.5% of all PAD patients
undergoing amputation. Few revascularisation attempts
may explain the high amputation rates in Hungary.25
Remarkably, Slovakia is the only country with increasing
major amputation rates, taking the second place after
Hungary, and followed by Austria. All other countries
showed a declining trend during the 4 year observation of
this study. Taking all possible explanations into consider-
ation, Slovakia showed the highest prevalence of diabetes
(7.8%), the second lowest life expectancy (76.3 years), the
second lowest gross domestic product per capita (27,700 US
Dollars), the second lowest healthcare expenditures (5.5%),
and showed the second lowest proportion of never smokers
(70.5%), compared with the other countries. The most dis-
tinguishing differences between countries with higher and
lower major amputation rates were apparently economic
factors, where only Hungary had lower GDP and healthcare
expenditures as well as the highest amputation rates.
Despite data not being age adjusted in this study, ampu-
tation rates decreased over time. Considering the global
epidemiological transition towards an older age distribution,
the declining trend in major amputation rates would prob-
ably have been even more pronounced if adjusted for age.
While major amputation rates decreased over time, despite
the short time period studied, minor amputation incidences
increased during the same study period. It should be noted,
however, that many minor amputations are performed in
outpatient clinics that tend to have a less complete regis-
tration of surgical procedures than inpatient care, making
data for minor amputations less robust.
Reported post-operative mortality among patients un-
dergoing major amputations varied almost fourfold be-
tween the extremes (6% in Finland compared with 21% in
Hungary), both deﬁned as status at the time of discharge.
Core variables such as proportion of patients at age  65
years, proportion of diabetics, or reimbursement system
could not explain the observed differences. The wide range
may however, be partly explained by observation time. For
example, the higher Swedish mortality rates compared with
Finland and Norway may be inﬂuenced by the studied time
frame, as mortality was deﬁned as death during the ﬁrst 30
post-operative days in Sweden (where the linkage to the
population registry makes it possible to study death with
almost 100% accuracy) and as death during hospital stay in
Finland and Norway. Information on other inﬂuencing fac-
tors on in hospital mortality, such as availability of stepdown facilities allowing for early discharge from hospital,
was not available, and thus not taken into account.
Reported diabetes prevalence among amputees varied
between 25.7% in Finland and 74.3% in Slovakia. The vari-
ation can only be explained to some extent by differences in
diabetes prevalence according to the International Diabetes
Federation Atlas (6.0% vs. 7.8%, respectively). Apart from
disparities in diagnosis and patient selection, data regis-
tration and coding practice may have an impact.
As expected, increased age was associated with an in-
crease in major amputation rates: patients aged 65 years
and above showed up to an almost ﬁve times increased rate
(Fig. 5).
Limitations
This study has several limitations. Despite using a clear and
detailed study protocol and search algorithm to permit com-
parable data extraction from governmental databases, there
are still signiﬁcant differences in coding practices, collection of
administrative data, and availability of data. Therefore, the
external and internal validities of these results remain ques-
tionable, leading to a risk of bias and possibly misleading
messages.26 Especially when working with data frommultiple
registries, the risk of type I error becomes signiﬁcant.27 As a
result of data privacy regulations, no patient related follow up
was available for this study. Therefore, each procedure (e.g.
primary toe amputation, secondary major amputation) was
collected and analysed as an individual event. Second, infor-
mation regarding comorbidities or outcome following hospital
discharge was not addressed. Robust data on lifestyle factors
such as smoking habits and physical activity, were difﬁcult to
obtain. It is assumed that the practices of coding and regis-
tration have remained rather stable over time in each country,
making the time trends more robust than the head to head
comparisons between countries. This is of particular impor-
tance for the comparison of mortality. Signiﬁcant differences
in time of follow up (30 days vs. the in hospital period) and
discharge practice between countries may decrease the val-
idity of the comparison of this outcome. Furthermore, it is
unlikely that coding practices would alter in a harmonious way
all over Europe and Australasia, which makes the main ﬁnding
of this study, that major amputation rates are decreasing over
time, even more plausible.
CONCLUSION
This international audit from 12 countries on amputation
related to PAD showed a declining trend of major ampu-
tations over time. These ﬁndings, along with the de-
mographic development, are important and require
reﬂection, further research, and action to make healthcare
providers and governments aware of the need to
strengthen both prevention and treatment of limb threat-
ening ischaemia among PAD patients in an effort to
decrease major lower limb amputations.
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Autologous Arteriovenous Loop Fistula in the Forearm With Transposition of
a Matured Forearm Cephalic Vein
Efstratios Georgakarakos a,*, Nikolaos Tsikliras b
a Department of Vascular Surgery, ‘Democritus’ University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece
b Dialysis Unit, General Hospital of Xanthi, Xanthi, Greecerevisions. On clinical examination it was noted that the patent brachiocephalic anastomosis (arrowhead) was still draining
A 61 year old dialysis patient presented with thrombosed brachiocephalic arteriovenous ﬁstula in the left arm after multiple
into a considerable length of dilated cephalic vein in the forearm (presenting bruit). Under local anaesthesia a sufﬁcient
length of the cephalic vein was dissected free and mobilised (Panel A) to loop back (Panel B, dotted line) for an end to end
anastomosis to the basilic vein in the cubital fossa (Panel B, arrow). The presented technique avoids any artiﬁcial conduit and
spares the brachial site for future interventions.sity of Thrace, 68100 Dragana, Alexandroupolis, Greece.
vier B.V. All rights reserved.
